Related Experiment Video
Updated: Aug 8, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Prevalence of enterotoxigenic Bacteroides fragilis in patients with diarrhea: a controlled study
Bengul Durmaz1, Mehmet Dalgalar, Riza Durmaz
1Faculty of Medicine, Department of Clinical Microbiology, Inonu University, 44069 Malatya, Turkey. bdurmaz@inonu.edu.tr
Abstract:
In this age matched controlled study performed in Malatya, a city in east region of Turkey, enterotoxigenic Bacteroides fragilis (ETBF) was investigated in stool specimens obtained from children and adults with and without diarrhea. A nested polymerase chain reaction (PCR) method was used to detect the enterotoxin gene of B. fragilis in a total of 418 stool samples, including 221 samples from 117 children (aged 0-16 years) and 104 adults (aged >16 years) with diarrhea, and 197 samples from 102 children and 95 adults as control group that was the same age group with those having diarrhea. ETBF was detected in 13 of 117 diarrheal children (11.1%) and 8 of 102 control children (7.8%) (P>0.05). In children aged 1-5 years, the rate of ETBF was significantly higher in patients than in controls (25% versus 9.5%, respectively; P<0.05). On the other hand ETBF was detected similar rates (2.2% and 2.4%, respectively) in children younger than 1 year in both patients and controls. ETBF positivity was not significantly difference between patient and control groups who were older than 5 years of age and adults. The frequency of ETBF in the controls was slightly higher in older persons than in younger ones; however, it was not significant. The rate of ETBF as the only enteropathogen in the patients with ETBF was significantly higher than in controls with ETBF (88% versus 39%, respectively; P<0.02). We found that in east region of Turkey, the prevalence of ETBF was higher in the childhood diarrhea, particularly in aged 1-5. As the only enteropathogen, ETBF may play an important role in diarrheal diseases. Persons after 6 years old can be carrier for ETBF regardless diarrhea.
Insights
Enterotoxigenic Bacteroides fragilis (ETBF) is more prevalent in children aged 1-5 with diarrhea in Turkey. ETBF may be a significant cause of childhood diarrhea and can be carried by individuals over 6 years old.
Area of Science:
- Microbiology
- Pediatrics
- Infectious Diseases
Background:
- Enterotoxigenic Bacteroides fragilis (ETBF) is a potential cause of diarrhea.
- The prevalence and role of ETBF in diarrheal diseases, particularly in specific geographic regions and age groups, require further investigation.
Purpose of the Study:
- To investigate the prevalence of ETBF in children and adults with and without diarrhea in Malatya, Turkey.
- To determine the association between ETBF and diarrheal diseases in different age groups.
- To assess the role of ETBF as a sole enteropathogen in diarrheal cases.
Main Methods:
- An age-matched controlled study was conducted.
- A nested polymerase chain reaction (PCR) method was used to detect the enterotoxin gene of B. fragilis.
- A total of 418 stool samples were analyzed from children (0-16 years) and adults (>16 years), including diarrheal patients and a control group.
Main Results:
- ETBF was detected in 11.1% of diarrheal children and 7.8% of control children (P>0.05).
- In children aged 1-5 years, ETBF prevalence was significantly higher in patients (25%) than controls (9.5%) (P<0.05).
- ETBF was found as the sole enteropathogen more frequently in diarrheal patients (88%) than in controls (39%) (P<0.02).
Conclusions:
- ETBF prevalence is higher in childhood diarrhea, especially in children aged 1-5 years, in eastern Turkey.
- ETBF may play a significant role as an enteropathogen in diarrheal diseases.
- Individuals over 6 years old can be carriers of ETBF, irrespective of diarrheal status.
Related Concept Videos
Bacterial Gastroenteritis
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Microbiota of the Large Intestine
Giardiasis
Microbiota of the Stomach and Small Intestine